['diabetic macular edema']
['faricimab', 'ranibizumab']

        Inclusion Criteria:

          -  Macular edema associated with diabetic retinopathy

          -  Decreased visual acuity attributable primarily to DME

          -  Diagnosis of diabetes mellitus

        Exclusion Criteria:

          -  High risk proliferative diabetic retinopathy

          -  Cataract surgery within 3 months of Baseline, or any other previous intraocular
             surgery

          -  Uncontrolled glaucoma

          -  Current or history of ocular disease in the study eye other than DME

          -  Major illness or major surgical procedure within 1 month prior to Day 1

          -  Uncontrolled blood pressure

          -  Glycosylated hemoglobin (HbA1c) greater than (>) 12 percent (%) at screening

          -  Untreated diabetes mellitus or initiation of oral anti-diabetic medication or insulin
             within 4 months prior to Day 1
      